Interleukin-12 is a heterodimeric, pro-inflammatory cytokine that is a key driver of cell-mediated immunity. Clinical interest in IL-12 is significant due to its potent anti-tumor activity and efficacy in controlling certain infectious diseases such as Leishmaniasis and Listeria infection.
Abstract:
Interleukin-12 is a heterodimeric, pro-inflammatory cytokine that is a key driver of cell-mediated immunity. Clinical interest in IL-12 is significant due to its potent anti-tumor activity and efficacy in controlling certain infectious diseases such as Leishmaniasis and Listeria infection.
For clinical applications, the ease of production and purification of IL-12 and the associated cost continues to be a consideration. In this context, we report a simple and effective heparin-affinity based purification of recombinant human IL-12 (hIL-12) from the serum-free supernatants of stable IL-12-transduced HEK293 cells. Fractionation of culture supernatants on heparin Sepharose columns revealed that hIL-12 elutes as a single peak in 500 mM NaCl. Coomassie staining and Western blot analysis showed that hIL-12 eluted in 500 mM NaCl is homogeneous.Purity of hIL-12 was ascertained by RP-HPLC and ESI-MS analysis, and found to be ~98%.Western blot analysis, using monoclonal antibodies, demonstrated that the crucial intersubunit disulfide bond linking the p35 and p40 subunits is intact in the purified hIL-12. Results of far UV circular dichrosim, steady-state tryptophan fluorescence, and differential scanning calorimetry experiments suggest that purified hIL-12 is in its stable native conformation.
Enzyme linked immunosorbent assays (ELISAs) and bioactivity studies demonstrate that hIL-12 is obtained in high yields (0.31 ± 0.05 mg/ mL of the culture medium) and is also fully bioactive. Isothermal titration calorimetry data show that IL-12 exhibits a moderate binding affinity (Kd(app) = 69 ± 1 µM) to heparin. The purification method described in this study is expected to provide greater impetus for research on the role of heparin in the regulation of the function of IL-12. In addition, the results of this study provide an avenue to obtain high amounts
Introduction:
Interleukin-12 (IL-12), previously known as natural killer cell stimulatory factor (NKSF) and cytotoxic lymphocyte maturation factor (CLMF), is a heterodimeric cytokine comprised of p40 and p35 subunits linked by an inter-subunit disulfide bridge [1] . Among its many pleiotropic functions, IL-12 has been shown to induce: (i) IFN production; (ii) proliferation of activated T and NK cells; and (iii) TH1 differentiation [2] . These functions are mediated by binding of intact IL-12 to its heterodimeric transmembrane receptor complex consisting of two chains, IL-12R1
and IL-12R2 [3] .
In addition to bridging the innate and the adaptive branches of the immune system, IL-12 has demonstrated remarkable activity in controlling infectious diseases such as Leishmaniasis and Listeria infection as well as inhibiting tumor growth [4] [5] [6] . Regarding the latter, IL-12 has shown potent antitumor and antimetastatic activity in a range of preclinical tumor models [7] [8] [9] [10] [11] [12] [13] .
Unfortunately, severe toxicities associated with repeated systemic delivery of IL-12 have dampened enthusiasm for its use in the clinic. Nevertheless, interest remains high for the development of novel delivery strategies to maintain IL-12's bioactivity while mitigating toxicity. In addition, in a recent National Cancer Institute-sponsored workshop, a committee of cancer immunotherapy experts ranked IL-12 third among immunotherapeutic agents with high potential for use in treating cancer [14] .
A significant obstacle to the continued exploration of IL-12 is the limited and expensive supply of recombinant IL-12 due to the lack of an efficient method for its overexpression and purification. Several attempts to produce recombinant IL-12 through a variety of host systems including bacteria, yeast, insect, and plants, have not met with much success [15] [16] [17] [18] [19] .
Biologically active IL-12 is glycosylated and therefore methods using lower eukaryotes and prokaryotes, which lack complete post-translational modification machinery have proven to be largely inefficient [20] . In addition, attempts to overexpress recombinant IL-12, fused to purification tags, in mammalian cells have also been limited [21] . Relatively low protein expression yields, the potential for undesirable antigenic epitopes due to extra amino acids left behind after cleavage of the protein purification tag, and the risk of contamination of recombinant IL-12 samples with proteases used for removal of protein purification tag(s), has severely hampered interest in the production of affinity tag fused recombinant IL-12 in mammalian cells.
This study describes an effort to overcome the limitations of current IL-12 purification protocols using IL-12 producing HEK293 cells grown in serum-free media in a Hollow Fiber bioreactor that allows high-density growth without any animal components. After demonstrating that IL-12 is a strong intrinsic heparin binding protein, a simple one-step heparin affinity based purification method for IL-12 was developed. The simple method described in this study resulted in large yields of highly pure IL-12 that could be used to trigger intensive development of novel IL-12-based therapeutics.
Materials and methods:
Materials: L-glutamine, HEPES buffer, trypsin-EDTA, G418 sulfate, Low molecular weight heparin (~3000Da) and 100 x stock of penicillin(10,000 Units/mL)/streptomycin (10mg/mL) were purchased from Sigma (St. Louis, MO). Cell culture media components, including FBS, horse serum, DMEM, and AMEM were purchased from Thermo Scientific (Rockford, IL).
[Type text] 8 CDM-HD serum replacement was purchased from Fiber Cell Systems (Frederick, MD).
Recombinant hIL-12 was purchased from Peprotech (Rocky Hill, NJ). Bicinchoninic acid (BCA) protein assay kits were purchased from Thermo Scientific (Rockford, IL). All antibodies used for Western were purchased from eBiosciences (San Diego, CA). Heparin Sepharose columns were purchased from GE Healthcare Bio-Sciences (Piscataway, NJ).
Heparin string identification:
The heparin binding segment search was performed using a recently developed heparin binding string search algorithm [22] . Amino acid sequences (in the FASTA format) corresponding to the p40 and p35 subunits were independently used to identify putative heparin binding segments. After completion of the search on the subject sequence (hIL-12), the string tool provides an output file detailing the amino acid sequence and the position of the potential heparin binding segments in hIL-12 [22] . Based on the information generated by the search algorithm, the surface electrostatic potential distribution map of hIL-12 was confirmed using the PBEQ solver available at CHARMM-GUI [23, 24] . Electrostatic potential map of hIL-12 was visualized using the surface view representation available in PyMol (a molecular visualization program) [25] .
Generation of HEK293 cell lines overproducing human IL-12p70:
The DNA vector (plasmid AG181) optimized for maximal production of human IL-12p70, expressing the p40 subunit from the hCMV promoter and the p35 subunit from the simian CMV promoter [26] , was used for the generation of stable clonal HEK293-H cell lines. Highly purified, endotoxin-free DNA plasmid (Qiagen EndoFree Giga kit, Hilden, Germany) was linearized by restriction enzyme digestion and purified using the Nucleotide Removal Kit (Qiagen) and ethanol precipitated under sterile conditions. One million HEK293-H cells (Invitrogen, number 11631-017) were stably transfected by the calcium phosphate coprecipitation technique using 10 g of HindIII-linearized hIL-12p70 (plasmid AG181) and 1 g of EcoRI linearized pRSVneo used for selection. The cells were cultured in complete media consisting of DMEM with 10% v/v FCS, 1x penicillin/streptomycin (100Units/mL, 100g/mL), and 500 g/mL G418. Clone 293H/78 was among the highest producers with good growth properties. The cells were expanded and seeded in serum-free media (DMEM with 10% CDM-HD serum replacement, 1x penicillin/streptomycin, and 250 g/mL G418) in a hollow fiber system (FiberCell Systems Inc., Frederick, MD) as described previously [27] . Cell supernatants (20 mL) were harvested daily and assayed for IL-12 levels by ELISA. IL-12 production was stable for up to 3 months.
Supernatants collected between days 26 to 36 were used for the purification procedure.
Purification of hIL-12 using heparin Sepharose affinity chromatography: Cell culture supernatants (20mL) were loaded onto a pre-equilibrated heparin Sepharose (10mm*100 mm)column in 10 mM phosphate bu`ffer, pH 7.2. Protein elution was performed at 4 C in the same buffer using an increasing step-wise gradient of sodium chloride at a constant elution rate of 1 mL per minute. Protein elution was monitored at 280 nm with an Econo UV Monitor (BioRad, Inc., USA). The eluted protein was desalted and concentrated using a 10 kDa molecular weight cut-off at a rotor speed of 2500 x g. Protein concentration was estimated using the molar extinction coefficient value at A280 nm and also using the dye binding methods with BCA [28] and Bradford protein estimation assays using BSA as standard [29] .
SDS-PAGE:
Purified hIL-12 was resolved on 10% SDS-PAGE under both reduced and nonreduced conditions according to the method of Laemmli [30] . Gels were independently stained with Coomassie Brilliant Blue R-250 and ProQ Emerald green specific for staining glycoproteins [31] .
Western blot analysis: Purified hIL-12 was separated on 10% SDS-PAGE under both reduced and non-reduced conditions. The proteins were transferred onto a nitrocellulose membrane and blocked using 5% skim milk in 1X Tris buffered saline with Tween-20 (TBS-T) (10mM Tris, 100mM NaCl, 0.05% Tween-20; pH 7.4) at room temperature for 1hr. Membranes were washed once with 0.2% BSA in 1X TBS-T. Mouse anti-hIL-12 antibodies specific for p70, p40 and p35 (eBiosciences Inc., San Diego, CA) were added at a 1:2000 dilution and incubated overnight. A secondary anti-mouse IgG antibody conjugated with alkaline phosphatase (Genescript Inc., Piscataway, NJ) was added to the membrane at a 1:2500 dilution and incubated at 4 ο C for 2 hours. Bands were visualized using NBT/BCIP as a substrate for the alkaline phosphatase.
Reversed-phase HPLC analysis: hIL-12 purity was assessed via reversed-phase HPLC analysis.
Samples were loaded onto a reversed phase C-18 column with the mobile phase consisting of two solvents (A) 0.1% TFA in water and (B) 0.1% TFA in acetonitrile. Using two type of gradient conditions, one a linear gradient of 5-70% of B for 30minutes and two a step gradient of 0-15% of B for 15 minutes, 15-65% of B for 45 minutes and 65-100% of B for 15 minutes hIL-12 sample purified from heparin Sepharose was resolved on a two different C18 matrices, one
Zorbax column with 300SB-CN column with 4.6 x 250mm dimension containing 5 µM porous particle with 300 Å pore size (Agilent, Santa Clara, CA) and two PRP-3 column with 2.1 x 150mm dimension containing 10 µM porous particle with 300 Å pore size (Hamilton, Reno, NV). The flow rate of the mobile phase was set at 1mL/min. The elution of protein (at 25  C) was monitored at 280 nm using a Hitachi L-74006 UV-Visible detector.
Measurement of hIL-12 concentration and bioactivity: hIL-12 concentration was determined via ELISA (Human IL-12 p70 ELISA Ready-SET-Go, Biosciences Inc., San Diego, CA)
according to the manufacturer's instructions [26] . Bioactivity of purified hIL Circular dichroism: CD analysis of hIL-12 was performed using a Jasco spectropolarimeter.
Far-UV CD spectrum for hIL-12 (100 µM) was recorded in 1X PBS pH 7.4 using a quartz cell of 0.1 mm path length with a scan speed of 50 nm/second. Suitable blank corrections were made to obtain the final CD spectrum. CD data was expressed in molar ellipticity (deg. cm 2 .dmol -1 ).
Differential scanning calorimetry:
Heat capacity of hIL-12 was measured as a function of temperature at pH 7.2 using a Differential Scanning Calorimeter (NANO DSCIII) with a ramping temperature of 1 o C/min from 10 o C to 90 o C. hIL-12 was subjected to degassing in 1X PBS pH 7.4 before the acquisition of DSC data. Thermal denaturation of hIL-12 was performed at a protein concentration of ~100 µM. Both the heating and cooling cycles were recorded to examine the reversibility of the thermal unfolding process.
ESI-MS analysis:
Electrospray ionization (ESI) mass spectrometry was performed on a Bruker ESI-QTOF machine using a quadrupole time-of-flight mass spectrometer. Purified hIL-12 sample (0.1mg/mL) was subjected to desalting using ZipTip TM , mixed with methanol (with 0.1% formic acid) and directly infused into the ESI source using a syringe pump. Mass spectra were obtained in a positive ion mode.
Results and discussion:
Mammalian overexpression of hIL-12: Human embryonic kidney cells (HEK293-H) were previously transduced with the dual promoter plasmid (AG181, DPhuIL-12p70 ) expressing both subunits p40 and p35 from the same vector from 2 promoters arranged in counter-clockwise orientation [26] . The stable, high producing cell clone 293-H/78 was cultured in a hollow fiber bioreactor in serum-free medium. SDS-PAGE of culture supernatants showed two prominent closely moving bands corresponding to the p40 (Mw ~40 kDa) and p35 (Mw ~ 35 kDa) subunits of hIL-12 ( Fig. 1) . The band representing the 35 kDa subunit was observed to be quite diffuse compared to that of the 40 kDa subunit (Fig. 1 ). Similar observations, on the diffuse nature of the band corresponding to the p35 band, were previously made when the SDS PAGE gels of IL-when the SDS gels are stained with Emerald green stain which recognizes glycosylated proteins.
The average concentration of hIL-12, as assessed by ELISA, in culture supernatants was 364  62 g/mL. In addition, the total amount of protein in culture supernatants was measured using the Bradford protein assay. Results indicated that hIL-12 accounts for ~25% of total proteins in culture supernatants.
Identification of heparin binding strings in hIL-12:
Several cytokines such as, the fibroblast growth factors, vascular endothelial growth factors and interferon-γ, are known to specifically bind to heparin [34] [35] [36] [37] . In silico analyses have shown that heparin binding proteins contain amino acid sequences characterized by special patterns of basic amino acids and other natural amino acids [38, 39] . The importance of the distribution of these patterns for heparin binding has been corroborated using three-dimensional crystal and solution structures of several heparin binding cytokines [36, 37, 40, 41] . In this context, the occurrence of such conspicuous amino acid patterns has been used to predict binding affinity of proteins to heparin [42] [43] [44] [45] . In silico analysis of the cytokine amino acid sequence database, using the recently developed algorithm, revealed the presence of putative heparin binding amino acid segments in cytokines which, to date, had not previously been annotated as heparin binding proteins (data not shown). One among those cytokines is IL-12. In this context, it is important to mention that Hasan et al (1999), using an ELISA approach on IL-12-BSA fusion protein, suggested that IL-12 is a heparin binding protein [46] . However, the heparin binding specificity of IL-12 was ambiguous due to the presence of BSA in the fusion protein. BSA is known to non-specifically bind to various ligands including heparin [47] .
hIL-12 was found to contain two potential heparin binding sites located on the p40 subunit: LKDQKEPKNK (amino acid segment, 117-126) and QVQGKSKREKK (amino acid segment, 276-286) ( Fig. 2A) . Interestingly, the p35 subunit did not show the presence of any potential heparin-binding string(s) (Fig. 2A) . Mapping these putative heparin binding segments on the three-dimensional structure of hIL-12 reveals that the basic residues within each segment are located in close spatial proximity, creating two positively charged clusters in the p40 subunit (Fig. 2B) . The presence of these clusters creates a conducive microenvironment for binding of negatively charged molecules such as heparin. This led to the prediction that hIL-12 can potentially bind to polyanions like heparin (Fig. 2C) .
Purification of hIL-12 using heparin affinity chromatography: Because hIL-12 contains putative heparin binding strings, it was hypothesized that its heparin binding affinity could be exploited for purification using heparin Sepharose affinity chromatography. Heparin is a highly sulfated molecule and is known to interact with its specific protein partners through electrostatic interactions [38, 45] . Therefore, purification of heparin binding proteins is achieved by heparin Sepharose affinity chromatography using a simple salt gradient [48] [49] [50] [51] .
Fractionation of proteins in culture supernatants using heparin Sepharose affinity chromatography, under a stepwise NaCl gradient, produced three prominent peaks (Fig. 3A) .
SDS-PAGE gels of the different fractions eluted in a NaCl gradient, detected independently by
Coomassie blue staining, silver staining and polyclonal IL-12 antibodies, revealed that most of the contaminating proteins were eluted in the wash buffer and in 100 mM NaCl (Fig. 3A) . Only, a very small peak was observed in 200 mM NaCl where no distinct band was observed in SDS-PAGE (Figs.3A, 3B lane 3) . A faint band corresponding to the p40 subunit was detected in the 300 mM NaCl fraction (Figs.3A, 3B , lane 4) but the majority of the secreted IL-12 was eluted in the 500 mM NaCl fraction (Figs.3A, 3B lane 5, and 3C ). In addition, ProQ emerald green staining of the fraction eluted in 500 mM NaCl (Fig. 3C) suggests that purified IL-12 is glycosylated.
Bradford protein assay and ELISA measurements were carried out to assess if contaminants not detectable by Coomassie staining, were present in the 500 mM NaCl fraction. Reverse phase HPLC chromatography was used to quantitate the purity of hIL-12 isolated from heparin Sepharose column. Two different elution conditions were used to monitor any potential contaminants present in the sample. hIL-12 eluted as a single peak both under linear ( Fig. 4A ) and stepwise gradient conditions (Fig. 4B) . Measurement of peak area in the reversed phase HPLC profile indicates that the purity of hIL-12 is greater than 98% (Fig. 4A and   4B ). ESI-MS analysis of purified hIL-12 revealed a relatively broad peak corresponding to an average molecular mass of 65,074 Da. This value is higher than the expected molecular mass value of 62,024 Da calculated from the amino acid sequence of IL-12. The observed broadening of the ESI mass peak and the disparity between the experimental and theoretical molecular mass can be attributed to the reported glycosylation of hIL-12 [26, [52] [53] [54] . Several previous studies have reported the presence of p40 dimer as a contaminant in IL-12 heterodimer preparations.
Interestingly, the ESI mass spectra of hIL-12 did not show the presence of p40 homodimer. It appears that the p40 homodimer, which if formed, could possibly have eluted from the heparin Sepharose column in lower concentrations of NaCl. The heparin binding pocket is possibly less accessible in the p40 dimer than in its monomeric form.
Integrity of the inter-subunit disulfide bond in the purified recombinant hIL-12: The p35 and p40 subunits in IL-12 are bridged by an inter-subunit disulfide bond [55] [56] [57] . This bond has been shown to be critical for the bioactivity of IL-12 as both p35 and p40 must bind to their respective receptor chains, i.e. IL-12R2 and IL-12R1, respectively, for activation of the receptor [55] [56] [57] .
The presence of the intermolecular disulfide bond between the p35 and p40 subunits was examined using three different monoclonal antibodies specific for the intact heterodimer, the p40 subunit, or the p35 subunit (Fig. 5) . SDS-PAGE under non-reducing conditions showed a single band corresponding to a molecular weight of ~75 kDa suggesting that the inter-subunit disulfide bond bridging the p35 and p40 subunit is intact in the purified hIL-12. As expected, the constituent p35 and p40 subunits were detected under reduced conditions, in the presence of 1% v/v -mercaptoethanol, indicating that the inter-subunit disulfide bond is intact in the purified recombinant IL-12 (Fig. 5) .
Conformation of purified hIL-12:
To verify that purified hIL-12 is in its native conformation [58] , far UV circular dichroism (CD) was used to measure the secondary structural conformation. Far UV CD spectrum of purified hIL-12 ( Fig. 6A) showed a minimum centered at around 210 nm and a broad shoulder in the 222 nm region signifying that the protein backbone contains both -helix and -sheet structural elements. This observation is consistent with the crystal structure of IL-12 which shows that the p40 and p35 subunits are predominantly in -sheet and -helical conformations, respectively [57] .
Intrinsic steady state tryptophan fluorescence provides useful information on the tertiary structure of proteins [59, 60] . The steady state fluorescence spectrum of purified recombinant hIL-12 showed that the wavelength maximum is centered at 343 nm suggesting that the protein has a well-defined tertiary structure with the indole ring of the tryptophan residues buried in a partially hydrophobic environment of the protein (Fig. 6B ).
Differential Scanning Calorimetry (DSC) directly measures the thermal stability of purified hIL-12 [61] . The DSC thermogram of purified hIL-12 shows a Tm, the temperature at which 50% of the protein population exists in denatured state(s), of 65  0.3 C, (Fig. 6C) . The DSC data, in conjunction with the Far UV CD and steady state tryptophan fluorescence results, clearly suggest that the purified recombinant hIL-12 is in a structured and stable conformation.
Bioactivity of purified hIL-12: IFN- production by the IL-12-responsive NK-92MI cell line was used to compare the biological activities of purified hIL-12 and commercially available hIL-12. The bioactivity assay showed that IFN- levels induced by the purified IL-12 shows similar activity as the commercial hIL-12 (Fig. 7) . This observation is quite encouraging considering the fact that, unlike commercial IL-12 samples, no protein stabilizing agent was added to our purified IL-12 preparations.
IL-12 exhibits specific binding affinity to heparin:
The heparin binding affinity of IL-12
predicted by in silico analysis and successfully exploited for heparin-affinity chromatography was measured quantitatively using isothermal titration calorimetry (ITC). This experimental technique is very versatile because it can provide a direct measure of the binding affinity, binding stoichiometry, and thermodynamics of protein-ligand interactions. The isothermogram characterizing the IL-12-heparin interaction at 25C shows an exothermic hyperbolic curve suggesting that the interaction produced heat (Fig. 8) 
Conclusions:
The results of this study indicate that the heparin binding affinity of IL-12 can be successfully exploited to purify bioactive recombinant IL-12 from mammalian cultures in a single step without the use of protein affinity tags. This simple and efficient purification method can be expected to serve as trigger for intensive research efforts to better understand the role of heparin on the structure-function relationship of IL-12. In this context, it may be of interest to note that glycosaminoglycans such as, heparin and heparin sulfate play a crucial role in activation of transmembrane kinase receptors of cytokines [62] . In addition, the high yields of pure IL-12 obtained using the method described in this study will provide an avenue to embark on structural studies aimed at the development of novel IL-12 based therapeutics for the treatment of cancers and infectious diseases. In the inset, mass spectrum showing the peak of hIL-12 molecule with average experimental molecular mass. 2) containing 100 mM NaCl. Thermograms were corrected for background noise.
Legends to figures
The experiments were performed at a scan rate of 1 °C/min. 
